Global Organ-On-Chip Market: Key Highlights
Global Organ-On-Chip Market: Key Market Dynamics
Global Organ-On-Chip Market: Regional Overview
North America is expected to dominate the organ-on-chip market during the forecasted period. This growth can be attributed to some of the factors such as the availability of a wide range of services offered by major players, and an increase in toxicological testing of chemicals on the different types of organ cells. Additionally, huge investment is being made by private and public institutions for their research. For instance, in February 2018, two pharmaceutical companies Roche and Takeda have partnered for investing Emulate’s organ chip for their research and development labs.
Europe is expected to have substantial growth in the organ-on-chip market. This growth can be attributed to the presence of pharmaceutical and biotechnology firms and research facilities. Moreover, the initiatives are taken by the government to ensure better health for its people. For instance, in November 2018, The new European Organ-on-chip Society (EUROoCS) was launched at the third International Organ-on-chip Symposium, in the Netherlands. This will encourage the development and coordination of Organ-on-chip research in Europe.
Global Organ-On-Chip Market: Key Players Overview
Emulate, Inc. offers advance product innovation, design, and safety across a range of applications including drug development, agriculture, cosmetics, food, and chemical-based consumer products. the company engaged continuously expanding their organ-chips and disease models through collaborations with industry partners and internal R&D programs. In May 2018, Emulate, Inc has collaborated with pharma giant AstraZeneca’s Innovative Medicines and Early Development (IMED) Biotech Unit to embed its Organs-on-chips technology within the laboratories.
InSphero was incorporated in 2009 and has set the global gold standard for advanced, yet easy-to-use 3D tissue-based assay solutions for predictive compound classification. The company offers products for the pharmaceutical, biotech, cosmetic, and chemical sectors. In October 2018, InSphero AG has completed a collaborative project with the FHNW University in Switzerland to develop a 3D organ-on-a-chip assay for predicting metabolic stability of low clearance compounds in pharmaceutical drug development.
About Forencis Research
Forencis Research is a B2B market research, intelligence and advisory firm engaging in market research and consulting services across leading industries, globally. Our robust and meticulous research team provides high growth and niche syndicated reports, customized reports and consulting reports to the diverse global fortune clientele and intellectual institutions. Forencis Research database is a constantly evolving pool of market research reports and white paper studies which helps companies to foster accelerated revenue growth in global and regional markets.
Our robust research methodology is designed to constantly map the high growth markets in various industries. This facilitates enhanced decision-making capabilities to our clients. Our robust research methodology is designed to constantly map the high growth markets in various industries. This facilitates enhanced decision-making capabilities to our clients. We strive to help our clients to foray into uncharted space to attain increased revenue growth for the present as well as the future.
Phone: +1 (720) 306 9020